Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers
暂无分享,去创建一个
Daniel J Schaid | Jeffrey L Myers | Jeffrey M Slezak | Thomas A Sellers | Carol Reynolds | T. Sellers | D. Schaid | S. McDonnell | L. Hartmann | C. Reynolds | J. Myers | T. Sebo | R. Jenkins | Shannon K McDonnell | Robert B Jenkins | J. Slezak | Thomas J Sebo | Lynn C Hartmann | Camilo Adem | Cheryl L Soderberg | C. Adem | C. L. Soderberg | J. Myers | Cheryl L. Soderberg
[1] M. Stratton,et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. , 1998, Journal of the National Cancer Institute.
[2] P. O’Connell,et al. Analysis of loss of heterozygosity in 399 premalignant breast lesions at 15 genetic loci. , 1998, Journal of the National Cancer Institute.
[3] C. Bodian,et al. Prognostic significance of benign proliferative breast disease , 1993, Cancer.
[4] D. Cosgrove. The breast , 1999, European Radiology.
[5] D. Henson,et al. Benign breast changes and the risk for subsequent breast cancer: an update of the 1985 consensus statement. Cancer Committee of the College of American Pathologists. , 1998, Archives of pathology & laboratory medicine.
[6] S. Fuqua,et al. Histological and biological evolution of human premalignant breast disease. , 2001, Endocrine-related cancer.
[7] A. Ashworth,et al. The pathology of familial breast cancer: The pathology of familial breast cancer How do the functions of BRCA1 and BRCA2 relate to breast tumour pathology? , 1999, Breast Cancer Research.
[8] David L. Page,et al. Diagnostic Histopathology of the Breast , 1988 .
[9] P. Rosen,et al. Medullary carcinoma of the breast. A clinicopathologic study with 10 year follow‐up , 1977, Cancer.
[10] M. Swift,et al. Breast and other cancers in families with ataxia-telangiectasia. , 1987, The New England journal of medicine.
[11] M. Skolnick,et al. Inheritance of proliferative breast disease in breast cancer kindreds. , 1990, Science.
[12] M. Stanley,et al. Atypia in breast fine-needle aspiration smears correlates poorly with the presence of a prognostically significant proliferative lesion of ductal epithelium. , 1993, Human pathology.
[13] S. Cummings,et al. Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[14] L. Strong,et al. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. , 1990, Science.
[15] David L. Page,et al. Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression , 1995, Nature Genetics.
[16] T. Sellers,et al. Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. , 2001, Journal of the National Cancer Institute.
[17] Y. Miki,et al. Clinicopathologic analysis of BRCA1‐ or BRCA2‐associated hereditary breast carcinoma in Japanese women , 1999, Cancer.
[18] F. Melsen,et al. Prognostic comparison of three classifications for medullary carcinomas of the breast , 1997, Histopathology.
[19] M. King,et al. BRCA1 and BRCA2 and the genetics of breast and ovarian cancer. , 2001, Human molecular genetics.
[20] R. J. Rosser. Consensus conference on the classification of ductal carcinoma in Situ , 1998, Cancer.
[21] Thomas Ludwig,et al. Development of mammary adenocarcinomas by tissue-specific knockout of Brca2 in mice , 2001, Oncogene.
[22] Dieter Niederacher,et al. Multistep carcinogenesis of breast cancer and tumour heterogeneity , 1997, Journal of Molecular Medicine.
[23] G M Lenoir,et al. Hereditary breast cancer: Pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage , 1996, Cancer.
[24] I. Andrulis,et al. HER‐2/neu status and tumor morphology of invasive breast carcinomas in Ashkenazi women with known BRCA1 mutation status in the Ontario Familial Breast Cancer Registry , 2002, Cancer.
[25] J. Sudbø,et al. Gene-expression profiles in hereditary breast cancer. , 2001, The New England journal of medicine.
[26] S J London,et al. A prospective study of benign breast disease and the risk of breast cancer. , 1992, JAMA.
[27] J. Feunteun. Breast cancer and genetic instability: the molecules behind the scenes. , 1998, Molecular medicine today.
[28] T. Ludwig,et al. Tumorigenesis in mice carrying a truncating Brca1 mutation. , 2001, Genes & development.
[29] H M Jensen,et al. On the origin and progression of ductal carcinoma in the human breast. , 1973, Journal of the National Cancer Institute.
[30] M. Stratton. Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases , 1997, The Lancet.
[31] I. Ellis,et al. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. , 2002, Histopathology.
[32] D J Schaid,et al. Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer. , 1999, The New England journal of medicine.
[33] C. Key,et al. Prevalence of benign, atypical, and malignant breast lesions in populations at different risk for breast cancer. A forensic autopsy study , 1987, Cancer.
[34] D K Gaffney,et al. Pathobiologic characteristics of hereditary breast cancer. , 1998, Human pathology.
[35] R. Kempson,et al. In situ proliferative epithelial lesions of the breast. , 1992, Pathology.
[36] J. Tonascia,et al. Epidemiologic characteristics of benign breast disease. , 1977, American journal of epidemiology.
[37] T. Sellers,et al. Efficacy of contralateral prophylactic mastectomy in women with a personal and family history of breast cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] P. Chappuis,et al. Clinico-pathological characteristics of BRCA1- and BRCA2-related breast cancer. , 2000, Seminars in surgical oncology.
[39] M. Greene,et al. Genetics of breast cancer. , 1997, Mayo Clinic proceedings.
[40] S. Fosså,et al. Incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors. , 2001, Journal of the National Cancer Institute.